FORM 8-A
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
BIOMARIN PHARMACEUTICAL INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 68-0397820
- --------------------------------------------------------------------------------
(State of incorporation or organization) (I.R.S. Employer
Identification No.)
371 Bel Marin Keys Boulevard, Suite 210 Novato, CA 94949
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
NONE
- --------------------------------------------------------------------------------
Securities to be registered pursuant to Section 12(g) of the Act:
COMMON STOCK, par value $0.001 per share
- --------------------------------------------------------------------------------
(Title of class)
Item 1. Description of Registrant's Securities to be Registered
-------------------------------------------------------
BioMarin Pharmaceutical Inc. incorporates by reference the description of
its securities to be registered hereunder contained under the headings
"Description of Capital Stock" and "Shares Eligible for Future Sale" contained
in the Registrant's Registration Statement on Form S-1, including any amendments
thereto (File Number 333-77701).
Item 2. Exhibits
--------
The following exhibits are filed as a part of this registration
statement:
3.1A* Amended and Restated Certificate of Incorporation of the Registrant,
as filed on March 22, 1999.
3.1B Form of Amended and Restated Certificate of Incorporation of the
Registrant (to be filed with the Secretary of State of the State of
Delaware prior to the effectiveness of the offering).
3.2* Amended and Restated Bylaws of the Registrant.
4.1* Form of Amended and Restated Registration Rights Agreement by and
among the Registrant and the investors named therein.
4.2 Specimen Stock Certificate of the Registrant.
10.2* 1997 Stock Plan, as amended on December 22, 1998 and forms of
agreements thereunder.
10.3* 1998 Director Option Plan and forms of agreements thereunder.
10.4* 1998 Employee Stock Purchase Plan and forms of agreements
thereunder.
______________________
* Incorporated by reference to the Exhibits of the same number to the
Registrant's S-1 Registration Statement, including any amendments thereto (
File Number 333-77701).
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the Registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.
Date: July 15, 1999 BIOMARIN PHARMACEUTICAL INC.
By: /s/ Raymond W. Anderson
-------------------------------------
Raymond W. Anderson
Chief Financial Officer and Vice
President of Finance and
Administration (Principal Financial and
Accounting Officer)